BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2018
View Archived Issues
Pfizer reflects on milestones of fourth quarter 2017
Read More
EMA accepts fremanezumab MAA
Read More
Celgene begins tender offer for Juno Therapeutics
Read More
Takeda describes novel Toll-like receptor 4 antagonists
Read More
SYT7 identifies gastric cancer with hepatic metastasis
Read More
Novo Nordisk updates events of fourth quarter 2017
Read More
Astellas Pharma, Pfizer support research into role of AR in breast cancer
Read More
Shanghai Synergy initiates phase I/II study in China with hypidone in major depressive disorder
Read More
Phase III AEGIS-CKD study of Feraccru does not meet primary endpoint
Read More
NEOLAP trial interim results presented for patients with LAPC
Read More
A1M Pharma seeks Swedish clearance to begin phase I study of ROSgard
Read More
ReViral reports promising outcome from phase IIa challenge study of RV-521 in RSV
Read More
Tetra Bio-Pharma cleared to begin phase III trial of PPP-001 in patients with terminal cancer
Read More
Amgen discovers new sodium channel blockers
Read More
Novel beta-glucuronidase inhibitors patented by UNC Chapel Hill
Read More
Latvian Institute of Organic Synthesis presents seleopheno[h]chromene derivatives
Read More
PTGDR2 antagonists patented by Jiangsu Chia Tai Tianqing Pharmaceutical, Medshine Discovery
Read More
High rate of response seen with nivolumab/nab-paclitaxel treatment in PDAC
Read More
Asahi Kasei launches Kevzara in Japan
Read More
FDA grants orphan drug designation to Hanmi's LAPS glucagon analogue
Read More
Vancomycin-based vancapticins overcome Gram-positive bacterial resistance
Read More
Palatin initiates phase I study of melanocortin MC1 receptor agonist PL-8177
Read More
CtBP2 and CD44 found useful for risk stratification of GIST patients
Read More